Torres et al., 2024 - Google Patents
An overview of proprietary vehicles/bases for topical compounding medicines and cosmeticsTorres et al., 2024
View HTML- Document ID
- 8588049664475787789
- Author
- Torres A
- Almeida I
- Oliveira R
- Publication year
- Publication venue
- Cosmetics
External Links
Snippet
Compounding is currently an integral part of pharmacy practice, and it is essential to the provision of healthcare. Compounding is an important therapeutic option in all areas of medicine, with relevance to dermatological treatments. Compounding topical medicines can …
- 239000003814 drug 0 title abstract description 94
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
- A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycol [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/72—Cosmetic or similar toilet preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/02—Cosmetic or similar toilet preparations characterised by special physical form
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce, e.g. shopping or e-commerce
- G06Q30/02—Marketing, e.g. market research and analysis, surveying, promotions, advertising, buyer profiling, customer management or rewards; Price estimation or determination
- G06Q30/0241—Advertisement
- G06Q30/0251—Targeted advertisement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Barnes et al. | Vehicles for drug delivery and cosmetic moisturizers: review and comparison | |
| Nastiti et al. | Topical nano and microemulsions for skin delivery | |
| Montenegro et al. | Rosemary essential oil-loaded lipid nanoparticles: In vivo topical activity from gel vehicles | |
| Pavlou et al. | Skin care formulations and lipid carriers as skin moisturizing agents | |
| Pilch et al. | Liposomes with an ethanol fraction as an application for drug delivery | |
| Pelikh et al. | Hair follicle targeting and dermal drug delivery with curcumin drug nanocrystals—Essential influence of excipients | |
| Nastiti et al. | Novel nanocarriers for targeted topical skin delivery of the antioxidant resveratrol | |
| Mahdi et al. | Formulation and optimization of butenafine-loaded topical nano lipid carrier-based gel: characterization, irritation study, and anti-fungal activity | |
| Alam et al. | Investigation utilizing the HLB concept for the development of moisturizing cream and lotion: In-vitro characterization and stability evaluation | |
| Malik et al. | Formulation and characterization of chitosan-decorated multiple nanoemulsion for topical delivery in vitro and ex vivo | |
| Badria et al. | Formulation of sodium valproate nanospanlastics as a promising approach for drug repurposing in the treatment of androgenic alopecia | |
| Oliveira et al. | Patient-centric design of topical dermatological medicines | |
| Torres et al. | An overview of proprietary vehicles/bases for topical compounding medicines and cosmetics | |
| Chaiyana et al. | Dermal delivery enhancement of natural anti-ageing compounds from Ocimum sanctum linn. extract by nanostructured lipid carriers | |
| Dejeu et al. | Study for evaluation of hydrogels after the incorporation of liposomes embedded with caffeic acid | |
| Alyahya et al. | Preparation and optimization of itraconazole transferosomes-loaded HPMC hydrogel for enhancing its antifungal activity: 2^ 3 full factorial design | |
| Almostafa et al. | Novel formulation of fusidic acid incorporated into a myrrh-oil-based nanoemulgel for the enhancement of skin bacterial infection treatment | |
| Shah et al. | Nanostructured non-ionic surfactant carrier-based gel for topical delivery of desoximetasone | |
| Špaglová et al. | Microemulsions as solubilizers and penetration enhancers for minoxidil release from gels | |
| Kim et al. | Characteristics of skin deposition of itraconazole solubilized in cream formulation | |
| Kovács et al. | Effects of formulation excipients on skin barrier function in creams used in pediatric care | |
| Alkholifi et al. | Phospholipid-based topical nano-hydrogel of mangiferin: enhanced topical delivery and improved dermatokinetics | |
| Calienni et al. | Rheological and viscoelastic analysis of hybrid formulations for topical application | |
| Rompicherla et al. | Design, formulation, and evaluation of aloe vera gel-based capsaicin transemulgel for osteoarthritis | |
| Poomanee et al. | Optimization of Mangifera indica L. kernel extract-loaded nanoemulsions via response surface methodology, characterization, stability, and skin permeation for anti-acne cosmeceutical application |